Handok & Teva-Handok sign joint sales agreement of respiratory disease treatments in Korea
Handok Inc.(Chairman Young-Jin Kim) and Teva-Handok(CEO Sung-Dong Park) held an agreement ceremony for joint sales of Teva-Handok’s respiratory disease treatments at the Handok headquarters on 26 October.
Under the agreement, the two companies will jointly sell Teva-Handok’s respiratory disease ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
